A4VY58 AF NFT

Leucine--tRNA ligase

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeiepdkoz3qeh4hr6hv4vh6bekv5jggj2tnnwxl7j2g7txzjx55djly/metadata.json
IPFS of structure file: 
bafybeiaufh374qt5mqfujhueutufsrtudk4zeneaoq67ke3oetgp5ffpju/AF-A4VY58-F1-model_v2.pdb
First NFT owner address (eip-55): 
0x6308DDF1510b8a81bb24FEB0c698521800724898
First NFT owner address (bech32): 
genesis1vvydmu23pw9grweyl6cvdxzjrqq8yjycs3msz5
Current NFT ID #450439 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
450439
Accession (UniProt):
A4VY58
Name::
Leucine--tRNA ligase
Experimental Method:
Predicted structure
Sequence source:
STREPTOCOCCUS SUIS (STRAIN 05ZYH33)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT A4VY58 research and analysis (ICN3D with VR)

FASTA sequences

>sp|A4VY58|SYL_STRSY Leucine--tRNA ligase OS=Streptococcus suis (strain 05ZYH33) OX=391295 GN=leuS PE=3 SV=2 MSFYNHKEIEPKWQEFWAKNHTFKTGTDAEKPNFYALDMFPYPSGAGLHVGHPEGYTATDILSRYKRAQGYNVLHPMGWDAFGLPAEQYAMDTGNDPADFTAENIANFKRQINALGFSYDWDREVNTTDPNYYKWTQWIFTKLYEKGLAYEAEVPVNWVEELGTAIANEEVLPDGTSERGGYPVVRKPMRQWMLKITAYAERLLNDLEEVDWPESIKDMQRNWIGKSTGANVTFKIKDTDKDFTVFTTRPDTLFGATYAVLAPEHDLVDSITSAEQAEAVAEYKRQASLKSDLARTDLATDKTGVWTGAYAINPVNGKEIPIWIADYVLASYGTGAIMAVPAHDERDWEFAKQFGLDIIPVLEGGNVEEAPYTEDGAHINSDFLDGLNKEEAIAKMVAWLEENGVGQEKISYRLRDWLFSRQRYWGEPIPIIHWEDGTSTAVPENELPLVLPKTSDIKPSGTGESPLANLTDWLEVVREDGVKGRRETNTMPQWAGSSWYYLRYIDPHNDEKLADEDLLKAWLPVDIYIGGAEHAVLHLLYARFWHKFLYDLGVVPTKEPFQKLFNQGMILGTSYRDSRGALVATDKVEKRDGSFFHMETGEELEQAPAKMSKSLKNVVNPDDVVEQFGADTLRVYEMFMGPLDASIAWSEEGLEGSRKFLDRVYRLLTTKELVAENSGALDKVYNETVKTVTEHIEDLKFNTAIAQLMIFVNAANKEDKLYVDYAKGFVQLIAPFAPHLAEELWQGLANTGQSISYVAWPTYDESKLVESEVEIVVQIKGKVKARLTVAKDLAPAELEKVALADEKVQAEIAGQTVVKVISVPNKLVNIVVK